Knappertz Volker's most recent trade in Aurinia Pharmaceuticals Inc was a trade of 4,930 Common Stock done at an average price of $6.1 . Disclosure was reported to the exchange on Feb. 27, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc | Knappertz Volker | EVP, Research and Development | Sale of securities on an exchange or to another person at price $ 6.10 per share. | 27 Feb 2024 | 4,930 | 319,128 (0%) | 0% | 6.1 | 30,073 | Common Stock |
| Aurinia Pharmaceuticals Inc | Volker Knappertz | EVP, Research and Development | Sale of securities on an exchange or to another person at price $ 5.48 per share. | 20 Feb 2024 | 25,146 | 324,058 (0%) | 0% | 5.5 | 137,800 | Common Stock |
| Aurinia Pharmaceuticals Inc | Volker Knappertz | EVP, Research and Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 191,462 | 344,274 (0%) | 0% | 0 | Common Stock |